Associate Director
Regeneron
Auburn, United States
Ping Shao is an accomplished professional with a proven track record of leveraging her expertise in epidemiology, research design, and statistical methodology to lead end-to-end RWE studies, manage multi-stake holder relationships, and deliver high-quality, actionable insights that drive strategic business decisions. She holds a Master of Science in Epidemiology from Harvard T.H. Chan School of Public Health and a Bachelor of Medicine in Preventative Medicine from Sichuan University West China Medical School. Currently serving as the Associate Director of Pharmacoepidemiology Analytics at Regeneron Pharmaceuticals, Inc., Ping leads evidence generation across all phases of research to support early to late-stage and post-market oncology and other therapeutic area products. Her career includes roles such as Director of Biostatistics and Programming Oncology RWE at ConcertAI, Advanced Analytics Advisor at CVS Health, and Consulting Business Analyst at Verisk Health.
Disclosure information not submitted.
Tuesday, August 27, 2024
1:00 PM – 1:15 PM CEST
Risk of Uveitis Following COVID-19 Diagnosis
Tuesday, August 27, 2024
2:15 PM – 2:30 PM CEST